Science Explorer Back to mapMap
Discussion
Researcher · Universidad San Carlos · Paraguay

Gregory A. Maglinte

Gregory A. Maglinte publishes mostly in Genetics, Oncology and Pulmonary and Respiratory Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.

ORCID 0000-0001-7130-2557 OpenAlex
World rank
#1,777,459
of 7,710,434 ranked researchers
Rank in Paraguay
#27
of 884
Works
73
Citations
3.9k
Citations per work
53.5
h-index
10
i10-index 11Top 59% in Genetics (Medicine)
Gregory A. Maglinte

What does Gregory A. Maglinte research?

Gregory A. Maglinte's work is mostly in Medicine (61%), Economics, Econometrics and Finance (9%).

Health Sciences: 44 works · 60.8% of their workMedicine: 44 works · 60.8% of their workGenetics: 15 works · 21.0% of their workOncology: 9 works · 12.2% of their workPulmonary and Respiratory Medicine: 8 works · 10.5% of their workPathology and Forensic Medicine: 6 works · 8.8% of their workHematology: 6 works · 8.3% of their workEverything else: 22 works · 30.4% of their workSocial Sciences: 6 works · 8.8% of their workEconomics, Econometrics and Finance: 6 works · 8.8% of their workEconomics and Econometrics: 6 works · 8.8% of their workTHEIR WORKGregory A.Maglinte73works
Health Sciences61%Social Sciences9%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4460.8%
  2. Everything else2230.4%
    1. Economics, Econometrics and Finance68.8%
  1. 1Genetics21% of their works
  2. 2Oncology12% of their works
  3. 3Pulmonary and Respiratory Medicine10% of their works
  4. 4Economics and Econometrics9% of their works
  5. 5Pathology and Forensic Medicine9% of their works
  6. 6Hematology8% of their works

Research topics

Which keywords describe Gregory A. Maglinte's research?

The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Chemotherapy, Lymphoma, Classification and Molecular Profiling.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Rituximab512 topics
  2. Prognostic Factors432 topics
  3. Chronic Lymphocytic Leukemia371 topic
  4. Genomic Aberrations371 topic
  5. Chemotherapy222 topics
  6. Lymphoma222 topics
  7. Classification141 topic
  8. Molecular Profiling141 topic
  9. BCR-ABL121 topic
  10. Endoscopic Resection121 topic
  11. Gastric Cancer121 topic
  12. Imatinib121 topic
  13. Cetuximab101 topic
  14. Cost of Care101 topic
  15. Financial Toxicity101 topic
  16. KRAS Mutations101 topic
  17. CAR T Cells81 topic
  18. Chimeric Antigen Receptor81 topic
  19. Acute Lymphoblastic Leukemia61 topic
  20. Childhood Cancer61 topic

Where does Gregory A. Maglinte work?

Gregory A. Maglinte's main affiliation in the publication record is Universidad San Carlos, Paraguay.

How many publications and citations does Gregory A. Maglinte have?

OpenAlex counts 73 works and 3,903 citations for Gregory A. Maglinte, an h-index of 10, ranking #1,777,459 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Gregory A. Maglinte. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.